Founded in 2002, AccessClosure Inc. is a privately held medical device company pioneering innovative access site management products designed to address complex challenges in the cardiovascular and peripheral vascular markets. AccessClosure manufactures and distributes the Mynx Product Family of Vascular Closure Devices in the United States as well as in a growing number of countries. In just over five years, the Mynx has become the leading extravascular solution in the United States.
The Mynx Product Family of Vascular Closure Devices
The Mynx Product Family of Vascular Closure Devices seal the femoral artery using a unique conformable sealant, which dissolves within 30 days, leaving nothing behind but a healed artery. The device is available in two sizes, one for use with 5F procedural sheaths and another for use with 6F or 7F procedural sheaths.
The original Mynx device was authorized for CE Mark in January, 2007 and received initial FDA approval in May, 2007.
MynxGrip Vascular Closure Device:
Launched in 2012, MynxGrip introduced an improved sealant that provides the security of mechanical closure with the safety of an extravascular sealant. Learn more
Mynx Cadence Vascular Closure Device: Launched in 2011, Mynx Cadence offers a simple design and improved ease-of-use while maintaining all the benefits of the original Mynx. Learn more